天美传媒

Dr. Gaber serves as Chair of Houston Methodist's Department of Surgery.  He received his first academic appointment in 1987, as an Assistant Professor in the Department of Surgery at the University of Tennessee in Memphis. He became an Associate Professor there in 1991, and received his full professorship and was named to the Baptist Memorial Health Care Foundation chair of excellence in transplantation in 1994. While at the University of Tennessee, Dr. Gaber also held professorships in the Departments of Pharmacy and in the College of Nursing. He was also the Medical Director for the University of Tennessee Bowld Hospital, and the Methodist University Transplant Institute.

Dr. Gaber is a prolific researcher and has authored over 300 scientific papers, as well as more than 340 abstracts and numerous book chapters, and his research has been funded by numerous grants from the National Institutes of Health, the Juvenile Diabetes Research Foundation, and several national and local foundations. Dr. Gaber assumed his positions at the Houston Methodist Hospital and Research Institute in Houston in 2006.

While also conducting transplant immunotherapy research for liver and kidney whole organ transplants and allografts, the main focus of Dr. Gaber麓s research is in the transplantation of islets to alleviate diabetic complications. He and his collaborators have developed the protocol for long term islet culture and described the clinical transplantation of islets through the intestinal veins. Dr. Gaber麓s current studies center on the testing of gene therapy and other approaches to test for islet viability and assist the transplanted islets to develop a sustaining blood supply and resist rejection by the recipient's immune system.

, is a board-certified transplant surgeon at UC San Diego Health and professor in the Department of Surgery at UC San Diego Health. She specializes in liver, kidney, and pancreas transplantation surgery in adults and children. She performs operations in patients with conditions such as chronic kidney disease, chronic liver disease, liver cancer and diabetes.
Mekeel serves as chief of the Division of Transplant and Hepatobiliary Surgery where she leads a group of four surgeons performing over 250 transplants, living and deceased donor organ procurements, and other surgeries per year. She also serves as vice-chair of Quality for the Department of Surgery and program director for Surgical Quality at UC San Diego Health. In these roles, Mekeel oversees quality and safety for operating rooms and surgical subspecialties.
She is also program director of the UC San Diego Center for Transplantation. Her leadership helped the program achieve a record number of transplants with excellent outcomes in 2019. She is an advocate for health care quality and patient safety in organ transplantation and throughout the hospital.
Mekeel champions organ donation and transplantation both locally and nationally and has served nationally on the United Network of Organ Sharing Pediatric Committee and Operations and Safety committees. She is also a board member for the John Brockington Foundation, which raises money and awareness for transplantation and organ donation in San Diego.